Autolus Therapeutics plc American Depositary Share

AUTL

...

AUTL: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Show AUTL Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of AUTL by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AUTL's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on AUTL's company Twitter account

WallStreetBets

Number of mentions of AUTL in WallStreetBets Daily Discussion

AUTL News

Recent insights relating to AUTL

CNBC Recommendations

Recent picks made for AUTL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AUTL

Corporate Flights

Flights by private jets registered to AUTL